PI3Kδ (p110δ/p85α) Assay Kit

Catalog #
79799
$535 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The PI3Kδ (p110δ/p85α) Assay Kit is designed to measure PI3Kδ (PI3K-delta) activity for screening and profiling applications, using ADP-Glo® Kinase Assay as a detection reagent.

Need us to run inhibitor screens or profile your compounds against PI3Kδ (p110δ/p85α)? Check out our Kinase Screening Services.

Synonyms
PIK3CD, p110delta, Phosphoinositide-3-Kinase Catalytic Delta

PIK3R1, Phosphoinositide-3-Kinase Regulatory Subunit 1 (Alpha), GRB1, p85alpha, PI3K, pi3k

Product Info
Storage and Usage
Citations
Assay Kit Format
Luminescent
Supplied As
The PI3Kδ (p110δ/p85α) Assay Kit comes in a convenient 96-well format, with enough purified recombinant PI3Kδ enzyme, PI3K lipid substrate, ATP and kinase assay buffer for 100 enzyme reactions.
Materials Required But Not Supplied

ADP-Glo® Kinase Assay (Promega #V6930)
Microplate reader capable of reading luminescence
Adjustable micropipettor and sterile tips
30°C incubator

Format
Catalog
Number

Reagent

Amount

Storage
40628 PI3Kδ (p110δ/p85α) 15 µg -80°C

Avoid multiple
freeze/thaw
cycles!
79334 5x Kinase assay buffer 1.5 ml -20°C
79686 ATP (500 μM) 100 µl -20°C
40560 PI3K lipid substrate
(Packaged separately, Do Not Freeze!)
500 µl 4°C
79696 96-well plate, white 1 Room Temp.
UniProt #
p110δ: O00329; p85α: 181523
Background
PI3Ks (Phosphatidylinositol 3-kinases) are lipid kinases that phosphorylate PIP2 (phosphatidylinositol 4,5-bisphosphate) to produce PIP3 (phosphatidylinositol 3,4,5-trisphosphate), which plays important roles in fundamental cellular activities such as cell growth, survival, migration, and metabolism. In human cancers, gain-of-function mutations of PI3Ks are found frequently, suggesting that PI3Ks are closely involved in tumorigenesis and that PI3K targeting inhibitors may be promising anticancer drug candidates.
References

Zhao W., et al. Acta Pharmaceutica Sinica B, 7(1): 27-37 (2017)